{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:28:13Z","timestamp":1790015293444,"version":"4.0.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["17\/363"],"award-info":[{"award-number":["17\/363"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Polypharmacy is associated with poor outcomes in older adults. Targeted deprescribing of anticholinergic and sedative medications may improve health outcomes for frail older adults. Our pharmacist-led deprescribing intervention was a pragmatic 2-arm randomized controlled trial stratified by frailty. We compared usual care (control) with the intervention of pharmacists providing deprescribing recommendations to general practitioners.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Community-based older adults (\u226565\u00a0years) from 2 New Zealand district health boards were recruited following a standardized interRAI needs assessment. The Drug Burden Index (DBI) was used to quantify the use of sedative and anticholinergic medications for each participant. The trial was stratified into low, medium, and high-frailty. We hypothesized that the intervention would increase the proportion of participants with a reduction in DBI \u2265 0.5 within 6\u00a0months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 363 participants, 21 (12.7%) in the control group and 21 (12.2%) in the intervention group had a reduction in DBI \u2265 0.5. The difference in the proportion of \u22120.4% (95% confidence interval [CI]: \u22127.9% to 7.0%) provided no evidence of efficacy for the intervention. Similarly, there was no evidence to suggest the effectiveness of this intervention for participants of any frailty level.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our pharmacist-led medication review of frail older participants did not reduce the anticholinergic\/sedative load within 6\u00a0months. Coronavirus disease 2019 (COVID-19) lockdown measures required modification of the intervention. Subgroup analyses pre- and post-lockdown showed no impact on outcomes. Reviewing this and other deprescribing trials through the lens of implementation science may aid an understanding of the contextual determinants preventing or enabling successful deprescribing implementation strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/gerona\/glac249","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T14:28:12Z","timestamp":1674570492000},"page":"1692-1700","source":"Crossref","is-referenced-by-count":39,"title":["Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A\u00a0Randomized Controlled Trial"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9518-9533","authenticated-orcid":false,"given":"Hamish","family":"Jamieson","sequence":"first","affiliation":[{"name":"Department of Medicine, Burwood Hospital, University of Otago , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-8540","authenticated-orcid":false,"given":"Prasad\u00a0S","family":"Nishtala","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmacology, Centre for Therapeutic Innovation, University of Bath , Bath , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6478-8541","authenticated-orcid":false,"given":"Hans Ulrich","family":"Bergler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Burwood Hospital, University of Otago , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan\u00a0K","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Medicine, Burwood Hospital, University of Otago , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-0344","authenticated-orcid":false,"given":"John\u00a0W","family":"Pickering","sequence":"additional","affiliation":[{"name":"Department of Medicine, Burwood Hospital, University of Otago , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6732-745X","authenticated-orcid":false,"given":"Nagham\u00a0J","family":"Ailabouni","sequence":"additional","affiliation":[{"name":"The Pharmacy Australian Centre of Excellence (PACE), School of Pharmacy, University of Queensland , Brisbane, Queensland, South Australia , Australia"},{"name":"UniSA Clinical and Health Sciences, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia , Adelaide, South Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-1388","authenticated-orcid":false,"given":"Rebecca","family":"Abey-Nesbit","sequence":"additional","affiliation":[{"name":"Department of Medicine, Burwood Hospital, University of Otago , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Gullery","sequence":"additional","affiliation":[{"name":"Planning, Funding and Decision Support, Canterbury District Health Board, General Manager of Planning, Funding and Decision Support; Lightfoot Solutions, Healthcare Systems, Specialist Advisor , Berkshire , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Deely","sequence":"additional","affiliation":[{"name":"Burwood Academy Trust , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-4595","authenticated-orcid":false,"given":"Susan\u00a0B","family":"Gee","sequence":"additional","affiliation":[{"name":"Psychiatry of Old Age Academic Unit, Canterbury District Health Board , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-1501","authenticated-orcid":false,"given":"Sarah\u00a0N","family":"Hilmer","sequence":"additional","affiliation":[{"name":"Geriatric Pharmacology, Faculty of Medicine and Health, Northern Clinical School, Kolling Institute, University of Sydney and Royal North Shore Hospital , St Leonards, New South Wales , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-9376","authenticated-orcid":false,"given":"Dee","family":"Mangin","sequence":"additional","affiliation":[{"name":"Primary Care Research Group, University of Otago , Christchurch , New Zealand"},{"name":"Department of Family Medicine, McMaster University , Hamilton, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"2023082713554079600_CIT0001","volume-title":"Prescription Drug Use Among Adults Aged 40\u201379 in the United States and Canada. no.\u00a0347","author":"Hales","year":"2019"},{"key":"2023082713554079600_CIT0002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","article-title":"Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe","volume":"78","author":"Mid\u00e3o","year":"2018","journal-title":"Arch Gerontol Geriat."},{"key":"2023082713554079600_CIT0003","volume-title":"Polypharmacy Management by 2030: A\u00a0Patient Safety Challenge","author":"Mair","year":"2017","edition":"2"},{"key":"2023082713554079600_CIT0004","author":"Health Quality and Safety Commission New Zealand","year":"25, 2021"},{"issue":"1","key":"2023082713554079600_CIT0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.2008.224","article-title":"The effects of polypharmacy in older adults","volume":"85","author":"Hilmer","year":"2009","journal-title":"Clin Pharmacol Ther."},{"issue":"9","key":"2023082713554079600_CIT0006","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/jgs.17145","article-title":"Frailty implications for exercise participation and outcomes in patients with heart failure","volume":"69","author":"Mudge","year":"2021","journal-title":"J Am Geriatr Soc."},{"key":"2023082713554079600_CIT0007","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1159\/000516532","article-title":"Polypharmacy and frailty among hemodialysis patients","volume":"145","author":"Kimura","year":"2021","journal-title":"Nephron."},{"key":"2023082713554079600_CIT0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.maturitas.2021.01.005","article-title":"Prevalence and association of continuous polypharmacy and frailty among older women: a longitudinal analysis over 15\u00a0years","volume":"146","author":"Thiruchelvam","year":"2021","journal-title":"Maturitas."},{"issue":"5","key":"2023082713554079600_CIT0009","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/07853890.2011.573499","article-title":"Drug burden index associated with function in community-dwelling older people in Finland: a cross-sectional study","volume":"44","author":"Gnjidic","year":"2012","journal-title":"Ann Med."},{"issue":"21","key":"2023082713554079600_CIT0010","first-page":"5469","article-title":"Problems associated with deprescribing of proton pump inhibitors","volume":"20","author":"Helgadottir","year":"2019","journal-title":"Int J Mol Med."},{"issue":"1","key":"2023082713554079600_CIT0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40266-017-0511-5","article-title":"Drug burden and its association with falls among older adults in New Zealand: a national population cross-sectional study","volume":"35","author":"Jamieson","year":"2018","journal-title":"Drug Aging."},{"issue":"7","key":"2023082713554079600_CIT0012","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/gerona\/gly176","article-title":"Drug burden index and its association with hip fracture among older adults: a national population-based study","volume":"74","author":"Jamieson","year":"2019","journal-title":"J Gerontol A\u00a0Biol Sci Med Sci."},{"issue":"2","key":"2023082713554079600_CIT0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/07853890.2016.1252053","article-title":"Drug burden index and change in cognition over time in community-dwelling older men: the CHAMP study","volume":"49","author":"Jamsen","year":"2017","journal-title":"Ann Med."},{"issue":"1309","key":"2023082713554079600_CIT0014","article-title":"Anticholinergic drugs in geriatric psychopharmacology","volume":"13","author":"L\u00f3pez-\u00c1lvarez","year":"2019","journal-title":"Front Neurosci."},{"issue":"6","key":"2023082713554079600_CIT0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/gerona\/glaa222","article-title":"Anticholinergic\/sedative drug burden and subjective cognitive decline in older adults at risk of Alzheimer\u2019s disease","volume":"76","author":"Margolis","year":"2020","journal-title":"J Gerontol A\u00a0Biol Sci Med Sci."},{"issue":"8","key":"2023082713554079600_CIT0016","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med."},{"key":"2023082713554079600_CIT0017","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/CIA.S66660","article-title":"Drug Burden Index in older adults: theoretical and practical issues","volume":"9","author":"Kouladjian","year":"2014","journal-title":"Clin Interv Aging."},{"issue":"3","key":"2023082713554079600_CIT0018","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bcp.12975","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis","volume":"82","author":"Page","year":"2016","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"2023082713554079600_CIT0019","first-page":"201","article-title":"Deprescribing: what is it and what does the evidence tell us","volume":"66","author":"Thompson","year":"2013","journal-title":"Can J Hosp Pharm."},{"issue":"11","key":"2023082713554079600_CIT0020","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for community-dwelling older adults: a systematic review and meta-analysis","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med."},{"issue":"1","key":"2023082713554079600_CIT0021","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","article-title":"A systematic review of the evidence for deprescribing interventions among older people living with frailty","volume":"21","author":"Ibrahim","year":"2021","journal-title":"BMC Geriatr."},{"issue":"7","key":"2023082713554079600_CIT0022","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.46747\/cfp.6807e215","article-title":"Interventions to address polypharmacy in older adults living with multimorbidity","volume":"68","author":"Ali","year":"2022","journal-title":"Can Fam Physician."},{"issue":"9868","key":"2023082713554079600_CIT0023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet."},{"issue":"5","key":"2023082713554079600_CIT0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.18773\/austprescr.2017.055","article-title":"Prescribing for frail older people","volume":"40","author":"Hilmer","year":"2017","journal-title":"Aust Prescr"},{"issue":"4","key":"2023082713554079600_CIT0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/ageing\/afab003","article-title":"New horizons in the impact of frailty on pharmacokinetics: latest developments","volume":"50","author":"Hilmer","year":"2021","journal-title":"Age Ageing."},{"issue":"3","key":"2023082713554079600_CIT0026","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","article-title":"Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis","volume":"20","author":"Kua","year":"2019","journal-title":"J Am Med Dir Assoc."},{"issue":"1","key":"2023082713554079600_CIT0027","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jamda.2020.03.012","article-title":"Association of deprescribing with reduction in mortality and hospitalization: a pragmatic stepped-wedge cluster-randomized controlled trial","volume":"22","author":"Kua","year":"2021","journal-title":"J Am Med Dir Assoc."},{"issue":"3","key":"2023082713554079600_CIT0028","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s11096-019-00829-z","article-title":"Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study","volume":"41","author":"Kua","year":"2019","journal-title":"Int J Clin Pharm."},{"issue":"5","key":"2023082713554079600_CIT0029","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/gerona\/glab222","article-title":"Consumer attitudes towards deprescribing: a systematic review and meta-analysis","volume":"77","author":"Weir","year":"2022","journal-title":"J Gerontol A\u00a0Biol Sci Med Sci."},{"key":"2023082713554079600_CIT0030","author":"interRAI. Instruments overview. 2021. Accessed October 26, 2021"},{"key":"2023082713554079600_CIT0031","volume-title":"interRAI Home Care (HC) Assessment form and User\u2019s Manual. Version 9.1.3","author":"Morris","year":"2019"},{"key":"2023082713554079600_CIT0032","volume-title":"interRAI Contact Assessment (CA) Form and User\u2019s Manual: A\u00a0Screening Level Assessment for Emergency Department and Intake from Community\/Hospital","author":"Hirdes","year":"2010"},{"issue":"1","key":"2023082713554079600_CIT0033","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1472-6963-8-277","article-title":"Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system","volume":"8","author":"Hirdes","year":"2008","journal-title":"BMC Health Serv Res."},{"issue":"766).","key":"2023082713554079600_CIT0034","article-title":"Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community","volume":"22","author":"Bergler","year":"2021","journal-title":"Trials."},{"key":"2023082713554079600_CIT0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med."},{"issue":"8","key":"2023082713554079600_CIT0036","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac178","article-title":"Development and validation of a frailty index compatible with three interRAI assessment instruments","volume":"51","author":"Abey-Nesbit","year":"2022","journal-title":"Age Ageing."},{"issue":"1","key":"2023082713554079600_CIT0037","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0891988715598231","article-title":"Updating the cognitive performance scale","volume":"29","author":"Morris","year":"2015","journal-title":"J Geriatr Psychiatry Neurol."},{"issue":"1","key":"2023082713554079600_CIT0038","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12877-018-1016-8","article-title":"A\u00a0frailty index derived from a standardized comprehensive geriatric assessment predicts mortality and aged residential care admission","volume":"18","author":"Burn","year":"2018","journal-title":"BMC Geriatr."},{"issue":"6","key":"2023082713554079600_CIT0039","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol."},{"issue":"1","key":"2023082713554079600_CIT0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","article-title":"DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities","volume":"41","author":"Ailabouni","year":"2019","journal-title":"Int J Clin Pharm."},{"issue":"446","key":"2023082713554079600_CIT0041","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc."},{"key":"2023082713554079600_CIT0042","article-title":"History of the COVID-19 alert system","author":"Government of New Zealand","year":"3, 2021"},{"issue":"4","key":"2023082713554079600_CIT0043","doi-asserted-by":"crossref","first-page":"e0151066","DOI":"10.1371\/journal.pone.0151066","article-title":"Challenges and enablers of deprescribing: a general practitioner perspective","volume":"11","author":"Ailabouni","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"2023082713554079600_CIT0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12877-020-1442-2","article-title":"Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)\u00a9 into home medicines review: a protocol for a cluster-randomised clinical trial in older adults","volume":"20","author":"Kouladjian\u00a0O\u2019Donnell","year":"2020","journal-title":"BMC Geriatr."},{"issue":"1","key":"2023082713554079600_CIT0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12877-020-01870-8","article-title":"Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care: a cluster-randomised clinical trial","volume":"20","author":"Zechmann","year":"2020","journal-title":"BMC Geriatr."},{"issue":"7","key":"2023082713554079600_CIT0046","doi-asserted-by":"crossref","first-page":"e019042","DOI":"10.1136\/bmjopen-2017-019042","article-title":"Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial","volume":"8","author":"van\u00a0der\u00a0Meer","year":"2018","journal-title":"BMJ Open."},{"issue":"3","key":"2023082713554079600_CIT0047","doi-asserted-by":"crossref","first-page":"e0149984","DOI":"10.1371\/journal.pone.0149984","article-title":"Deprescribing in frail older people: a randomised controlled trial","volume":"11","author":"Potter","year":"2016","journal-title":"PLoS One."},{"key":"2023082713554079600_CIT0048","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-161","article-title":"Patient education and pharmacist consultation influence on non-benzodiazepine sedative medication deprescribing success for older adults","volume":"23","author":"Kuntz","year":"2019","journal-title":"Perm J."},{"issue":"18","key":"2023082713554079600_CIT0049","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA."},{"issue":"3","key":"2023082713554079600_CIT0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00228-019-02785-z","article-title":"Deprescribing of non-antiretroviral therapy in HIV-infected patients","volume":"76","author":"Blanco","year":"2020","journal-title":"Eur J Clin Pharmacol."},{"issue":"12","key":"2023082713554079600_CIT0051","doi-asserted-by":"crossref","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"Anderson","year":"2014","journal-title":"BMJ Open."},{"key":"2023082713554079600_CIT0052","author":"University of Sydney","year":"2021"},{"issue":"2","key":"2023082713554079600_CIT0053","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/fampra\/20.2.199","article-title":"Do clinical practice education groups result in sustained change in GP prescribing","volume":"20","author":"Richards","year":"2003","journal-title":"Fam Pract."},{"issue":"1","key":"2023082713554079600_CIT0054","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.sapharm.2017.01.003","article-title":"Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines","volume":"14","author":"Farrell","year":"2018","journal-title":"Res Social Admin Pharm."},{"issue":"7544","key":"2023082713554079600_CIT0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/bmj.38782.575868.7C","article-title":"Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial","volume":"332","author":"Fossey","year":"2006","journal-title":"BMJ."}],"container-title":["The Journals of Gerontology: Series A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glac249\/49170374\/glac249.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/78\/9\/1692\/51275593\/glac249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/78\/9\/1692\/51275593\/glac249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T13:56:29Z","timestamp":1693144589000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/78\/9\/1692\/7000356"}},"subtitle":[],"editor":[{"given":"Lewis A","family":"Lipsitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,1,24]]},"published-print":{"date-parts":[[2023,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glac249","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,1]]},"published":{"date-parts":[[2023,1,24]]}}}